Weis kicks off Little Ones program
SUNBURY, Pa. Weis Markets on Monday announced the launch of its new Weis Little Ones program, allowing customers to donate diapers, baby wipes and other infant care products to babies and families in need throughout its market area.
“According to a recent study, 1-in-3 moms does not have enough diapers or other basic baby supplies to take care of her baby,” stated Karen Buch, Weis Markets director of lifestyle initiatives. “This is a particularly challenging issue. While parents in financial need may be eligible to apply for government funds through [Women, Infants and Childern] or [Supplemental Nutrition Assistance Program] to offset food and formula costs, these supplemental funds cannot be used to purchase the other essential infant care items. With the support of our customers, we will help local food banks meet this critical need.”
Customers also can make monetary donations by purchasing $1, $3 and $5 vouchers. Weis Markets will match these customers’ donations, which then will be used to purchase Huggies diapers as part of the company’s Every Little Bottom program. All donations will be forwarded to local food banks that have agreed to dispense infant care items to families in need.
The program will run in Weis Markets’ stores Oct. 17 through Nov. 27.
Huggies Every Little Bottom study of 2,000 mothers in the United States and Canada noted that families who are unable to afford an adequate supply of diapers face difficult choices. Diaper need results in babies being kept in dirty diapers for longer periods or in them wearing washed disposable diapers, which result in increased irritation and make infants more prone to severe diaper rash.
The report found that mothers struggling with diaper needs miss school and work more frequently or they keep their child out of day care, which usually requires a day’s supply of diapers. In the report, one mother said, “Having a clean diaper not only keeps their child healthy and well, but lets them know that they’re cared for. I think it would be great if food banks and soup kitchens offered diapers also to those in need.”
Other major Weis Little Ones sponsors include Johnson’s, Weis Bear Essentials and Aveno Baby. Over the next six weeks, customers can purchase diapers, baby wipes, baby lotions, rattles or baby toys, baby shampoos, teethers, baby detergent and bibs or burp clothes, and can place them in designated donation carts.
PharmaLink gets orphan drug designation for Nefecon
STOCKHOLM The Food and Drug Administration has given orphan drug designation to a treatment for a rare kidney disease under mid-stage clinical development by privately owned Swedish drug maker PharmaLink, the company said.
The FDA granted the designation to Nefecon (PL-56), a treatment for IgA nephropathy, also known as Berger’s disease, a disorder that leads to end-stage kidney disease. The FDA gives orphan drug designation to incentivize development of treatments for rare and serious disorders.
“Today’s news marks a significant milestone for PharmaLink and increases the commercial value of Nefecon as it moves toward the marketplace,” PharmaLink managing director Johan Haggblad said. “We believe this product candidate has great potential in treating IgA nephropathy.”
Medco: Poor adherence may cause lack of response to medication
BOSTON When a patient isn’t showing a response to a medication, a common tactic the doctor might use is to increase the dosage. According to a new study, however, the ineffectiveness might be happening because the patient isn’t properly taking the medication.
The Medco Research Institute, the research arm of pharmacy benefit manager Medco Health Solutions, found that nearly one-third of patients given increased dosages of antidepressants were not regularly taking their original prescriptions. Data from the study recently were presented at the American Psychiatric Association’s 62nd Institute on Psychiatric Services in Boston.
Medco said the study showed doctors should monitor a patient’s adherence to their antidepressants before raising the dosage because poor adherence may contribute to disease relapse, thus leading to unnecessary dosage increases.
“A physician usually increases a dose when a patient is not responding to the current dosage,” Medco Neuroscience Therapeutic Resource Center national practice leader and lead study author David Muzina said. “But the analysis shows that the reason the dose may not be effective is that many patients are not taking their antidepressants as directed.”